Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

SEED Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support company formation, as well as early research and development of novel oncology therapeutics, devices, treatment-oriented information technology products, diagnostics, or tools. The objective of the SEED Award program is to start with an interesting technology and to progress it toward a commercially viable business opportunity, i.e., make it more attractive to private funding agents.

Award:  Up to $3 million over three years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas Diagnostic and Devices Company Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of diagnostic tests and devices to treat, detect, diagnose, monitor, and assist in the treatment of cancer. The applicant should be working toward submitting an Investigational Device Exemption (IDE) or a 501(k) or Premarketing Approval (PMA) and is typically within one year from filing an IDE (or later stage work.)

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas New Technologies Company Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of new and emerging technologies for the detection, diagnosis, prognosis, monitoring, or treatment of cancer. CPRIT created this RFA to fund new and emerging technology projects that do not easily fit into any of the three other CPRIT Product Development Research RFAs. Proposals may include, but are not limited to, bioinformatics, artificial intelligence, production of radionuclides or their precursors, manufacture of cell-based therapies, processes to improve the quality of the samples used for cancer research or clinical care, and biomanufacturing of therapeutics.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas Therapeutics Company Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of innovative therapeutics with a significant impact on the treatment of cancer.  The applicant is typically within one year from filing an IND/IDE or already in Phase 1.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million over a  period of five years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release June 21, 2022
Application Receipt June 21, 2022 - April 21, 2023
Application Review September 2022 - July 2023
Award Notification Continuous

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release June 21, 2022
Application Receipt June 21, 2022 - April 21, 2023
Application Review September 2022 - July 2023
Award Notification Continuous